Criteria to request pharmacoeconomic data and data sources for hospital formulary decisions

Drug Information Journal

Volumn 35, Issue 1, 2001, Pages 231-240

  Kulsomboon, V ^a   Palumbo, F B ^a   Mullins, C D ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Formulary decisions; Hospital; Pharmacoeconomics; Survey

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT;

BUDGET; COST CONTROL; DECISION MAKING; DRUG COST; ECONOMIC ASPECT; FOOD AND DRUG ADMINISTRATION; HEALTH ECONOMICS; HOSPITAL PHARMACY; PRIORITY JOURNAL; PUBLICATION; REVIEW;

EID: 0035090353     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150103500127     Document Type: Review

References (32)

1. Assessment and accountability: The third revolution in health care
2. A pharmaceutical marketing plan for the 21st century: Sociopolitical environment as a marketing factor
3. Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers
4. Formulary decision making process in a U.S. academic medical center
5. How to use structured decision making in developing therapeutic, cost-effective formulary systems
6. The system of objectified judgement analysis (SOJA): A tool in rational drug selection for formulary inclusion
7. Guidelines for authors and peer reviewers of economic submission to the BMJ
8. Pharmacoeconomics and formulary decision making
9. Applications of pharmacoeconomic for managed care pharmacy
10. Use and influence of pharmacoeconomics in decision making in hospitals
11. Pharmacoeconomic analysis in the formulary decision making process
12. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis
13. The effect of managed care on prescription drug costs and benefits
14. Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions
15. Economic analysis of health care technology: A report on principles
16. Emerging standardization in pharmacoeconomics
17. Evaluating the BMJ guidelines: Prospective audit of economic submissions to BMJ and the Lancet
18. Use of a pharmacoeconomic database to justify two additional pharmacists in a university hospital
19. Formulary management in an integrated health care system
20. Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada: Structure, application and manufacturer responsibilities
21. Incorporating clinical outcomes and economic consequences into drug formulary decisions: A practical approach
22. American Society of Health System Pharmacists national survey of pharmacy practice in acute care settings: Prescribing and transcribing - 1998
23. Application of pharmacoeconomics and outcome research in formulary decision making
24. American Society of Health System Pharmacists survey on ambulatory care responsibilities of pharmacists in integrated health systems - 1997
25. American Society of Health System Pharmacists survey of ambulatory care responsibilities of pharmacists in managed care and integrated health systems 1999
26. Reassessing the relevance of pharmacoeconomics analyses in formulary, decisions